The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
    1. About this group
    2. Reviews
      1. Acupuncture for treatment of irritable bowel syndromeReview
      2. Aminosalicylates for induction of remission or response in Crohn's diseaseReview
      3. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's diseaseReview
      4. Anti-tuberculous therapy for maintenance of remission in Crohn's diseaseReview
      5. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adultsReview
      6. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescentsReview
      7. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitisReview
      8. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's diseaseReview
      9. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's diseaseReview
      10. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's diseaseReview
      11. Biofeedback for treatment of chronic idiopathic constipation in adultsReview
      12. Budesonide for induction of remission in Crohn's diseaseReview
      13. Budesonide for maintenance of remission in Crohn's diseaseReview
      14. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromeReview
      15. Corticosteroids for maintenance of remission in Crohn's diseaseReview
      16. Curcumin for maintenance of remission in ulcerative colitisReview
      17. Cyclosporine A for induction of remission in severe ulcerative colitisReview
      18. Cyclosporine for induction of remission in Crohn's diseaseReview
      19. Endoscopic scoring indices for evaluation of disease activity in Crohn’s diseaseReviewMethodology
      20. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitisReviewMethodologyNew
      21. Enteral nutrition for maintenance of remission in Crohn's diseaseReview
      22. Enteral nutritional therapy for induction of remission in Crohn's diseaseReview
      23. Etrolizumab for induction of remission in ulcerative colitisReview
      24. Fish oil for induction of remission in ulcerative colitisReview
      25. Glutamine for induction of remission in Crohn's diseaseReview
      26. Helminth therapy (worms) for induction of remission in inflammatory bowel diseaseReview
      27. Herbal medicines for treatment of irritable bowel syndromeReview
      28. Histologic scoring indices for evaluation of disease activity in Crohn’s diseaseReviewMethodology
      29. Histologic scoring indices for evaluation of disease activity in ulcerative colitisReviewMethodology
      30. Homeopathy for treatment of irritable bowel syndromeReview
      31. Human growth hormone and glutamine for patients with short bowel syndromeReview
      32. Hypnotherapy for treatment of irritable bowel syndromeReview
      33. The impact of biological interventions for ulcerative colitis on health-related quality of lifeReview
      34. Interventions for growth failure in childhood Crohn's diseaseReview
      35. Interventions for prevention of post-operative recurrence of Crohn's diseaseReview
      36. Interventions for treating collagenous colitisReview
      37. Interventions for treating lymphocytic colitisReview
      38. Low dose naltrexone for induction of remission in Crohn's diseaseReview
      39. Methotrexate for induction of remission in refractory Crohn's diseaseReview
      40. Methotrexate for induction of remission in ulcerative colitisReview
      41. Methotrexate for maintenance of remission in Crohn's diseaseReview
      42. Methotrexate for maintenance of remission in ulcerative colitisReview
      43. Natalizumab for induction of remission in Crohn's diseaseReview
      44. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's diseaseReview
      45. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitisReview
      46. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisReview
      47. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's diseaseReview
      48. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisReview
      49. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's diseaseReview
      50. Oral budesonide for induction of remission in ulcerative colitisReview
      51. Osmotic and stimulant laxatives for the management of childhood constipationReview
      52. Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitisReview
      53. Probiotics for induction of remission in Crohn's diseaseReview
      54. Probiotics for induction of remission in ulcerative colitisReview
      55. Probiotics for maintenance of remission in Crohn's diseaseReview
      56. Probiotics for maintenance of remission in ulcerative colitisReview
      57. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and childrenReview
      58. Probiotics for the prevention of pediatric antibiotic-associated diarrheaReview
      59. Probiotics for treatment of Clostridium difficile-associated colitis in adultsReview
      60. Psychological interventions for treatment of inflammatory bowel diseaseReview
      61. Psychological treatments for the management of irritable bowel syndromeReview
      62. Recombinant human interleukin 10 for induction of remission in Crohn's diseaseReview
      63. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitisReview
      64. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitisReview
      65. Sargramostim (GM-CSF) for induction of remission in Crohn's diseaseReview
      66. Specialist nursing interventions for inflammatory bowel diseaseReview
      67. Stimulant laxatives for constipation and soiling in childrenReview
      68. Strategies for detecting colon cancer in patients with inflammatory bowel diseaseReview
      69. Tacrolimus (FK506) for induction of remission in refractory ulcerative colitisReview
      70. Tegaserod for the treatment of irritable bowel syndrome and chronic constipationReview
      71. Thalidomide and thalidomide analogues for induction of remission in Crohn's diseaseReview
      72. Thalidomide and thalidomide analogues for maintenance of remission in Crohn's diseaseReview
      73. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel diseaseReview
      74. Traditional corticosteroids for induction of remission in Crohn's diseaseReview
      75. Transcutaneous electrical stimulation (TES) for treatment of constipation in childrenReview
      76. Transdermal nicotine for induction of remission in ulcerative colitisReview
      77. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitisReview
      78. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's diseaseReview
      79. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's diseaseReview
      80. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitisReview
      81. Type I interferons for induction of remission in ulcerative colitisReview
      82. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisReview
      83. Vedolizumab for induction and maintenance of remission in ulcerative colitisReview
    3. Protocols
      1. 5-ASA for management of symptomatic uncomplicated diverticular disease (SUDD)Protocol
      2. Abdominal massage for the treatment of constipationProtocol
      3. Acupuncture for chronic constipationProtocol
      4. Adalimumab for induction of remission in Crohn's diseaseProtocol
      5. Adalimumab for maintenance of remission in Crohn's diseaseProtocol
      6. Adjuvant therapy with antidepressants for the management of inflammatory bowel diseaseProtocol
      7. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's diseaseProtocol
      8. Anti-IL-17 monoclonal antibody for induction of remission in Crohn's diseaseProtocol
      9. Anti-MAdCAM antibody for induction of remission in ulcerative colitisProtocol
      10. Antibiotics for induction and maintenance of remission in Crohn's diseaseProtocol
      11. Antibiotics for induction of remission in Crohn's diseaseProtocolWithdrawn
      12. Antibiotics for induction of remission in ulcerative colitisProtocol
      13. Antibiotics for the management of constipation predominant irritable bowel syndrome and chronic constipationProtocol
      14. Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressivesProtocol
      15. Bacille Calmette-Guerin (BCG) vaccine for induction of remission in Crohn's diseaseProtocol
      16. Biofeedback for treatment of irritable bowel syndromeProtocol
      17. Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysisProtocol
      18. Biological interventions for induction of mucosal healing in Crohn’s diseaseProtocol
      19. Biological interventions for maintenance of mucosal healing in Crohn’s diseaseProtocol
      20. Biomarkers for assessing disease activity in inflammatory bowel diseaseProtocolDiagnostic
      21. Botulinum toxin for the treatment of chronic idiopathic constipationProtocol
      22. Cannabis for the treatment of Crohn's diseaseProtocol
      23. Cannabis for the treatment of ulcerative colitisProtocolNew
      24. Certolizumab pegol for induction of remission in Crohn's diseaseProtocol
      25. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn’s diseaseProtocol
      26. A comparison of endoscopic and surgical treatment of strictures in patients with Crohn’s diseaseProtocol
      27. Cyclosporine for maintenance of remission in Crohn's diseaseProtocol
      28. Dietary interventions for induction and maintenance of remission in inflammatory bowel diseaseProtocol
      29. Fecal transplantation for recurrent or refractory Clostridium difficile diarrheaProtocol
      30. Fecal transplantation for treatment of inflammatory bowel diseaseProtocol
      31. Fiber and bulking agents for the treatment of chronic constipationProtocol
      32. Herbal medicines for the treatment of inflammatory bowel diseaseProtocol
      33. The impact of surgical therapies for inflammatory bowel disease on female fertilityProtocol
      34. Infliximab for induction of remission in Crohn's diseaseProtocol
      35. Infliximab for maintenance of remission in Crohn's diseaseProtocol
      36. Interleukin-11 for induction of remission in Crohn's diseaseProtocol
      37. Interventions for fatigue in inflammatory bowel diseaseProtocol
      38. Interventions for induction and maintenance of mucosal healing in Crohn's diseaseProtocol
      39. Interventions for induction of mucosal healing in ulcerative colitisProtocol
      40. Interventions for maintenance of mucosal healing in ulcerative colitisProtocol
      41. MRI scoring indices for evaluation of disease activity and severity in Crohn’s diseaseProtocolMethodology
      42. Mycophenolate mofetil for induction of remission in Crohn's diseaseProtocol
      43. Oral corticosteroids for induction of remission in ulcerative colitisProtocol
      44. Oral janus kinase inhibitors for induction of remission in ulcerative colitisProtocol
      45. Oral janus kinase inhibitors for maintenance of remission in ulcerative colitisProtocol
      46. Pharmacological interventions for the prevention and treatment of radiation colitis, enteritis and proctitisProtocolWithdrawn
      47. Physical activity for treatment of irritable bowel syndromeProtocol
      48. Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s diseaseProtocolWithdrawn
      49. Polyethylene glycol for chronic constipation in adultsProtocol
      50. Probiotic agents for the treatment of diarrhoea-predominant irritable bowel syndromeProtocol
      51. Probiotics for management of functional abdominal pain disorders in childrenProtocol
      52. Prucalopride for the treatment of chronic constipationProtocol
      53. Rectal corticosteroids for induction of remission in ulcerative colitisProtocol
      54. Rectal corticosteroids for maintenance of remission in ulcerative colitisProtocol
      55. Reflexology for treatment of constipationProtocol
      56. Short chain fatty acids (butyrate) for induction of remission in ulcerative colitisProtocol
      57. Somatostatin analogues for treatment of enterocutaneous fistulaProtocol
      58. Traditional Chinese medicinal herbs for induction of remission in ulcerative colitisProtocol
      59. Vedolizumab for induction and maintenance of remission in Crohn’s diseaseProtocolWithdrawn
      60. Vitamin D for the treatment of inflammatory bowel diseaseProtocol
      61. Withdrawal of drug therapy for patients with quiescent Crohn's diseaseProtocol
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH